Cronos Group Inc. (CRON) vs Xeris Biopharma Holdings, Inc. (XERS)
- Cronos Group Inc. CRON 3.22 +0.63%
- Xeris Biopharma Holdings, Inc. XERS 10.28 +2.09%
Cronos Group Inc. and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Xeris Biopharma Holdings, Inc. is the larger, with a market value of $1.8B against $1.2B — 1.6× the size. Xeris Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Cronos Group Inc. trades at 16.1×. Cronos Group Inc. grew revenue faster over the last twelve months: 37.5% against 36.3%. Cronos Group Inc. has the higher net margin (20.9% vs −5.12%) and the lower return on invested capital (−0.34% vs 18.9%). Across the 19 metrics below, Cronos Group Inc. leads on 10 and Xeris Biopharma Holdings, Inc. on 9.
Valuation
Profitability
| Metric | CRON | XERS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 45.86% | 86.58% | 53.94% |
| Operating margin | (0.96%) | 10.91% | 0.00% |
| Net margin | 20.91% | (5.12%) | 0.00% |
| Free cash flow margin | 27.61% | 16.60% | 0.00% |
| Return on equity | 3.33% | 118.22% | (0.40%) |
| Return on assets | 3.18% | (4.60%) | (3.32%) |
| Return on invested capital | (0.34%) | 18.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack